Priestley T, Laughton P, Myers J, Le Bourdellés B, Kerby J, Whiting P J
Merck, Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK.
Mol Pharmacol. 1995 Nov;48(5):841-8.
The pharmacological properties of two recombinant human N-methyl-D-aspartate (NMDA) receptor subtypes, comprising either NR1a/NR2A or NR1a/NR2B subunits permanently transfected into mouse L(tk-) cells, have been compared using whole-cell voltage-clamp electrophysiology. Glutamate was a full agonist at both receptors, having a modestly but statistically significant (p < 0.002) higher affinity for the NR2B- than the NR2A-containing receptor (microscopic Kd [mKd] = 0.76 and 0.43 microM, respectively). In comparison to glutamate, NMDA, quinolinic acid, and cis-2,3-piperidinedicarboxylic acid were partial agonists at both receptor subtypes. Maximal amplitude currents resulted when glutamate-site agonists were combined with either glycine or D-serine; both of these amino acids were, therefore, defined as full agonists at the glycine site. Glycine had an approximately 10-fold higher affinity (p < 0.0001) for NR2B- than for NR2A-containing receptors (mKd = 0.057 and 0.53 microM, respectively). D-Cycloserine, (+)-(3R)-3-amino-1-hydroxypyrrolidin-2-one, (+)-cis-(4R)-methyl-(3R)-amino-1-hydroxypyrrolidin-2-one, and 1-aminocyclobutanecarboxylic acid also had higher affinities for the NR2B-containing receptor but were partial agonists, at both receptor subtypes, unlike glycine. Agonist-evoked whole-cell currents were antagonized by D-(-)-2-amino-5-phosphonopentanoic acid, cis-4-(phosphonomethyl)piperidine-2-carboxylic acid, and 3-((R)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, all of which had slightly, but statistically significant, higher affinities (2.2-, 2.8-, and 5.5-fold, respectively) for the NR2A-containing receptor. Responses were also antagonized by the glycine-site antagonists 7-chlorokynurenic acid, 7-chloro-4-hydroxy-3-(3-phenoxy)phenylquinolin-2-(1H)-one, and (+/=)-4-(trans)-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino- 1,2,3,4- tetrahydroquinoline. The atypical NMDA antagonist ifenprodil showed the largest separation in functional affinity (IC50 values, 0.6 and 175 microM at NR2B- and NR2A-containing receptors, respectively). These experiments demonstrate the usefulness of permanently transfected L(tk-) cells for electrophysiological studies of recombinant NMDA receptor function and provide the first detailed functional pharmacological analysis of human NMDA receptor subtypes.
利用全细胞膜片钳电生理学方法,比较了两种重组人N-甲基-D-天冬氨酸(NMDA)受体亚型的药理学特性,这两种受体亚型分别由永久转染到小鼠L(tk-)细胞中的NR1a/NR2A或NR1a/NR2B亚基组成。谷氨酸对两种受体均为完全激动剂,对含NR2B的受体的亲和力略高于含NR2A的受体,具有统计学显著差异(p < 0.002)(微观解离常数[mKd]分别为0.76和0.43微摩尔)。与谷氨酸相比,NMDA、喹啉酸和顺式-2,3-哌啶二羧酸对两种受体亚型均为部分激动剂。当谷氨酸位点激动剂与甘氨酸或D-丝氨酸联合使用时,可产生最大幅度的电流;因此,这两种氨基酸在甘氨酸位点均被定义为完全激动剂。甘氨酸对含NR2B的受体的亲和力比对含NR2A的受体高约10倍(p < 0.0001)(mKd分别为0.057和0.53微摩尔)。D-环丝氨酸、(+)-(3R)-3-氨基-1-羟基吡咯烷-2-酮、(+)-顺式-(4R)-甲基-(3R)-氨基-1-羟基吡咯烷-2-酮和1-氨基环丁烷羧酸对含NR2B的受体也具有较高的亲和力,但与甘氨酸不同,它们在两种受体亚型上均为部分激动剂。激动剂诱发的全细胞电流可被D-(-)-2-氨基-5-膦酰基戊酸、顺式-4-(膦酰基甲基)哌啶-2-羧酸和3-((R)-2-羧基哌嗪-4-基)-丙基-1-膦酸拮抗,所有这些拮抗剂对含NR2A的受体的亲和力均略高,但具有统计学显著差异(分别高2.2倍、2.8倍和5.5倍)。甘氨酸位点拮抗剂7-氯犬尿氨酸、7-氯-4-羟基-3-(3-苯氧基)苯基喹啉-2-(1H)-酮和(+/=)-4-(反式)-2-羧基-5,7-二氯-4-苯基氨基羰基氨基-1,2,3,4-四氢喹啉也可拮抗反应。非典型NMDA拮抗剂ifenprodil在功能亲和力上的差异最大(IC50值,在含NR2B和含NR2A的受体上分别为0.6和175微摩尔)。这些实验证明了永久转染的L(tk-)细胞在重组NMDA受体功能电生理学研究中的实用性,并首次对人NMDA受体亚型进行了详细的功能药理学分析。